Dr. Reddy's Laboratories Ltd. ADR buy HSBC Holdings plc
Start price
05.06.25
/
50%
€13.80
Target price
05.06.26
€14.80
Performance (%)
-18.84%
End price
06.06.26
€11.20
Summary
This prediction ended on 06.06.26 with a price of €11.20. The price of Dr. Reddy's Laboratories Ltd. ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.84%. HSBC_Holdings_plc has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | 4.808% | 4.808% | -7.627% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% |
Comments by HSBC_Holdings_plc for this prediction
In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $16.90 price target on the stock, up previously from $14.44.
Ratings data for RDY provided by MarketBeat
In the thread Trading Dr. Reddy's Laboratories Ltd. ADR
Die von HSBC_Holdings_plc gewählte maximale Laufzeit wurde überschritten